Do you want to read an article? Please log in or register.
Causes of Death in Anticoagulated Patients With Atrial Fibrillation.
Atrial FibrillationHeart FailureThrombosis and StrokeTherapy and Intervention
Related content
Atrial FibrillationHeart Failure
The Use of Biomarkers to Predict Specific Causes of Death in Patients with Atrial Fibrillation: Insights from the ARISTOTLE Trial
Circulation.
Sharma A, Hijazi Z, Andersson U, Al-Khatib SM, Lopes RD, Alexander JH, Held C, Hylek EM, Leonardi S, Hanna M, Ezekowitz JA, Siegbahn A, Granger CB, Wallentin L
doi: 10.1161/
Atrial Fibrillation
Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase
Int J Cardiol.
Proietti M, Laroche C, Nyvad O, Haberka M, Vassilikos VP, Maggioni AP, Boriani G, Lip GYH; EORP-AF Pilot Investigators
doi: 10.1016/j.ijcard.2017.08.055.
Atrial Fibrillation
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation
J Am Coll Cardiol.
Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P, Poloczek M, Stasek J, Haman L, Branny M, Chovancik J, Cervinka P, Holy J, Kovarnik T, Zemanek D, Havranek S, Vancura V, Opatrny J, Peichl P, Tousek P, Lekesova V, Jarkovsky J, Novackova M, Benesova K, Widimsky P, Reddy VY, PRAGUE-17 Trial Investigators.
doi: 10.1016/j.jacc.2020.04.067.
Atrial FibrillationThrombosis and StrokeTherapy and Intervention
Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft Surgery and Patients With Nonvalvular Atrial Fibrillation
JAMA Cardiol.
Butt JH, Xian Y, Peterson ED, Olsen PS, Rørth R, Gundlund A, Olesen JB, Gislason GH, Torp-Pedersen C, Køber L, Fosbøl EL
doi: 10.1001/jamacardio.
Atrial FibrillationHeart, Artery and Coronary Diseases
The Efficacy and Safety of the Use of Non-Vitamin-K Antagonist Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials
Circulation.
Bennaghmouch N, de Veer AJWM, Bode K, Mahmoodi BK, Dewilde WJM, Lip GYH, Brueckmann M, Kleine E, Ten Berg JM
doi: 10.1161/CIRCULATIONAHA.
Atrial Fibrillation
Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction
J Am Heart Assoc.
Szummer K, Gasparini A, Eliasson S, Ärnlöv J, Qureshi AR, Bárány P, Evans M, Friberg L, Carrero JJ
doi: 10.1161/JAHA.
COMMENTED
Atrial Fibrillation
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants
★ 2
Recommended and commented by
Prof. Dr Sacha P. Salzberg, Faculty Member
J Am Coll Cardiol
Camm AJ, Cools F, Virdone S, Bassand JP, Fitzmaurice DA, Arthur Fox KA, Goldhaber SZ, Goto S, Haas S, Mantovani LG, Kayani G, Grierson Turpie AG, Antoon Verheugt FW, Kakkar AK, GARFIELD-AF Investigators.
doi: 10.1016/j.jacc.2020.07.045
Atrial Fibrillation
Association of Anticoagulant Therapy With Risk of Fracture Among Patients With Atrial Fibrillation
JAMA Intern Med.
Lutsey PL, Norby FL, Ensrud KE, MacLehose RF, Diem SJ, Chen LY, Alonso A
doi: 10.1001/jamainternmed.2019.5679.
Atrial Fibrillation
The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events
Europace.
Atar D, Berge E, Le Heuzey JY, Virdone S, Camm AJ, Steffel J, Gibbs H, Goldhaber SZ, Goto S, Kayani G, Misselwitz F, Stepinska J, Turpie AGG, Bassand JP, Kakkar AK
doi: 10.1093/europace/euz292.